As part of the annual Med Safety Week (#MedSafetyWeek) of the WHO Centre for Drug Safety Monitoring, AIPM is joining forces with the All-Russian Union of Public Associations of Patients and Roszdravnadzor to create a culture of responsible reports of undesirable reactions in society.
Patients play a crucial role in this safety chain. Discuss your medications and potential side effects with your healthcare provider, and report any adverse reactions, no matter how minor they are. Doctors and healthcare professionals should verify patients' understanding of their treatment plans and promptly report any suspected adverse reactions to pharmacovigilance systems.
Pharmaceutical companies serve as the bridge between scientific research and patient care. It is their duty to provide accurate information to healthcare providers and patients, adhering to Good Manufacturing Practice (GMP) and Good Pharmacovigilance Practice (GVP) standards.
Roszdravnadzor emphasizes that every report of an adverse reaction is crucial for enhancing medication safety. Through collective effort and information sharing, we can make medicines safer for all.
Join the Movement
AIPM and the All-Russian Union of Public Associations of Patients with Roszdravnadzor's support have created resources for patients about the significance of reporting adverse reactions and the steps to take if they occur.
You can download a brochure, and a video is available too:
Patients play a crucial role in this safety chain. Discuss your medications and potential side effects with your healthcare provider, and report any adverse reactions, no matter how minor they are. Doctors and healthcare professionals should verify patients' understanding of their treatment plans and promptly report any suspected adverse reactions to pharmacovigilance systems.
Pharmaceutical companies serve as the bridge between scientific research and patient care. It is their duty to provide accurate information to healthcare providers and patients, adhering to Good Manufacturing Practice (GMP) and Good Pharmacovigilance Practice (GVP) standards.
Roszdravnadzor emphasizes that every report of an adverse reaction is crucial for enhancing medication safety. Through collective effort and information sharing, we can make medicines safer for all.
Join the Movement
AIPM and the All-Russian Union of Public Associations of Patients with Roszdravnadzor's support have created resources for patients about the significance of reporting adverse reactions and the steps to take if they occur.
You can download a brochure, and a video is available too: